[3] Two research-context points follow from this
What Makes 1st Optimal Different 1
Observations relating to the impact of tirzepatide on bone are still very much in their infancy, but there are suggestions that this drug could improve bone strength and reduce fracture risk
Notably, only one hGM group (O15) acquired the TMA/TMAO-producing ability from its donor, whereas the other three hGM groups had undetectable plasma d9-TMA and d9-TMAO (Fig
Poorly reconstituted solutions form depots that artificially extend apparent half-life through delayed release rather than prolonged circulation
Within minutes of the infusion, the patients reportedly experienced nausea, vomiting, lightheadedness, chills, body aches and sneezing